Brief: Hofseth Biocare Q3 Oper Loss Narrows To NOK 33.1 Million
Nov 11 (Reuters) - Hofseth Biocare ASA HBC.OL :
* Q3 GROSS OPERATING REVENUE NOK 30.2M (13.7M)
* Q3 OPERATING LOSS (EBIT LOSS) AMOUNTED TO NOK 33.1M
(36.8M)
Source text for Eikon: ID:nGNE7TwNVC
Further company coverage: HBC.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Hofseth Biocare ASA
See all newsBrief: HBC Publishes Clinical Trial, Calls It Paradigm-Changing
Brief: Hofseth Biocare Says Demand Outlook For 2026 Is Improving Rapidly
Norway's Hofseth Biocare Q4 revenue rises on Human Nutrition demand
Brief: Hofseth BioCare To Cancel Subsequent Offering
Brief: Hofseth Biocare Announces Results Of Subsequent Offering